HUM:Hummingbird Resources and PAF:Pan African Resources both climbed 5% despite the price of gold bouncing above and below $1,800.
JLP:Jubilee Metals also rose 5% but is still well down on where it should be.
IES:Invinity Energy climbed 6% after announcing a big new order.
Share of the Week is SBTX:SkinBioTherapeutics, which cast aside its
recent dreadful form to climb 13% of my purchase price in the ISA and 15% in
my SIPP.
Thank goodness we didn't dip below the injection line.
Bang on the trend line but really need to be well above it.
Here's the ISA and shares portfolio after week 27 of year 7.
Weekly Change | |||
Cash | £33.30 |
+£0 | |
Portfolio cost | £72,195.21 | +£0 | |
Portfolio sell value (bid price-commission) | £46,566.98 | (-35.5%) | +£1,934.66 |
Potential profits | £2,095.29 | +£40 | |
Yr 7 Dividends | £22.16 | +£0 | |
Yr 7 Profit from sales | £3,664.29 | +£0 | |
Yr 7 projected avg monthly profit | £588.64 | (16.0%) | -£22.64 |
Total Dividends | £1,365.31 | +£0 | |
Total Profit from sales | £27,788.23 | +£0 | |
Average monthly cash profit |
£368.82 |
(10.0%) | -£1.09 |
(Sold stocks profit + Dividends - Fees / Months) |
|||
Compound performance | 65% | +0% |
JLP:Jubilee Metals added £40 to potential profits. The fact it takes a 5% rise to do that shows how few shares I have left. Value up nicely and long term performance stays at 10% but I fear will slip below very soon.
As with the overall chart, just avoided dropping below the injection line
Still well below the trend line so no chance of recovery very soon.
The SIPP looks like this after week 323 overall and week 11 of year 7.
Potential profits up £56 thanks to PAF:Pan African Resources, portfolio value up pleasingly and cash up due to a £30 tax rebate and my £130 monthly savings minus the AJ Bell SIPP admin charge of 16p.
Same story as the ISA
Slightly better as we're just above the trend line, but not enough to help flatten it.
Weekly Change | ||||
Cash | £571.47 | +£159.84 | ||
Portfolio cost | £80,526.94 | +£0 | ||
Portfolio sell value (bid price - commission) |
£51,912.63 | (-35.5%) | +£1,822.77 | |
Potential profits | £124.25 | +£56.98 | ||
Yr 7 Dividends | £81.54 | +£0 | ||
Yr 7 Interest | £0 | +£0 | ||
Yr 7 Profit from sales | £381.04 | +£0 | ||
Yr 7 projected avg monthly profit | £168.97 | (4.1%) | -£16.96 | |
Total Dividends | £3,285.93 | +£0 | ||
Total Interest | £0.20 | +£0 | ||
Total Profit from sales | £24,105.67 | +£0 | ||
Average monthly cash profit | £356.00 | (8.6%) | -£1.11 | |
(Sold stocks profit + Dividends - Fees / Months) |
||||
Compound performance | 54% | +0% |
Potential profits up £56 thanks to PAF:Pan African Resources, portfolio value up pleasingly and cash up due to a £30 tax rebate and my £130 monthly savings minus the AJ Bell SIPP admin charge of 16p.
Same story as the ISA
Slightly better as we're just above the trend line, but not enough to help flatten it.
The trading account looks like this after week 289 overall and week 29 of year 6.
A positive week despite DDDD:4D Pharma slipping yet again, as HUM:Hummingbird Resources climbed 5%. Still looking pretty grim though, and didn't even make up half of last week's losses.
Looks flat rather than an up-tick
Weekly Change | |||
Cash | £259.74 | +£0 | |
Portfolio cost | £2,374.14 | +£0 | |
Portfolio sell value (bid price - commission) | £765.18 | (-67.8%) | +£20.41 |
Potential profits | £0.00 | +£0 | |
Year 6 Dividends | £0.00 | +£0 | |
Year 6 Profit | £0.00 | +£0 | |
Yr 6 projected avg monthly profit | £0.00 | (0%) | +£0 |
Dividends | £60.10 | +£0 | |
Profit from sales | £937.88 | +£0 | |
Average monthly cash profit | £14.96 | (7.6%) | -£0.06 |
(Sold stocks profit + Dividends - Fees / Months) |
A positive week despite DDDD:4D Pharma slipping yet again, as HUM:Hummingbird Resources climbed 5%. Still looking pretty grim though, and didn't even make up half of last week's losses.
Looks flat rather than an up-tick
Still below the trend line. I feel like I've been writing that for a year - oh hold on - I have!
I'm beginning to wonder if the turn-around will ever come. I've been expecting
good news on many fronts for months now, but it either doesn't arrive at all,
or when it does is treated like bad news and the share price drops.
I seem to be invested in sectors that are just not popular at the moment. I
bought magic formula shares because the price was already cheap, but all
except one have dropped, and some have dropped significantly. At least they
are all still paying good dividends, but they are not making up for the big
drops in capital value.
I will be able to take another £2,000 from my work pension in a few weeks. I
need to decide whether to put it into one of my ludicrously underpriced shares
like OPTI:Optibiotix or DDDD:4D Pharma or stick to my guns and
get some more magic formula shares. Despite my temptation to average down on
OPTI and DDDD, I really should get the
diversity into my SIPP that magic formula gives me.
No comments:
Post a Comment